John Albritton
Obstetrics & Gynecology · Memphis, TNNPI 1659307163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $741 and has fallen 97.4% since, to $20 in 2025.
Across 121 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$267
- Pfizer$232
- Daiichi Sankyo Inc.$221
- Mayne Pharma Commercial LLC$160
- Amgen$159
- Astellas Pharma US Inc$121
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,17099%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $267 |
| Pfizer | 19 | $232 |
| Daiichi Sankyo Inc. | 14 | $221 |
| Mayne Pharma Commercial LLC | 11 | $160 |
| Amgen | 4 | $159 |
| Astellas Pharma US Inc | 2 | $121 |
| Therapeuticsmd, Inc. | 8 | $118 |
| Novo Nordisk | 1 | $114 |
| Avion Pharmaceuticals | 7 | $96 |
| Aspira Women's Health Inc | 1 | $90 |
| Mylan Pharmaceuticals Inc. | 5 | $70 |
| Exeltis, USA Inc. | 4 | $62 |
| Scynexis, Inc. | 4 | $61 |
| Shield Therapeutics Inc | 3 | $48 |
| Organon | 2 | $45 |
| Coopersurgical, Inc. | 3 | $41 |
| BD | 2 | $40 |
| Agile Therapeutics, Inc. | 2 | $39 |
| Duchesnay USA Incorporated | 2 | $33 |
| Bayer | 2 | $32 |
| AMAG Pharmaceuticals, Inc. | 2 | $24 |
| Evofem Biosciences, Inc. | 2 | $23 |
| Convatec Inc. | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Merck | 1 | $18 |
| Bausch Health US, LLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,194 in reported general payments places this provider in the 70th percentile of 763 obstetrics & gynecology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Raloxifene Hcl | 14 | $858 |
| Estradiol | 15 | $321 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Memphis
- Benjamin ChappellMemphis$37K
- Pallavi KhannaMemphis$18K
- Donna RandolphMemphis$18K
- Linda MosesMemphis$17K
- Belvia CarterMemphis$10K
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
- Larry FieldsKnoxville$323K
- Michael SwanNashville$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.